Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=204"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=204

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00717041-e320f201",
        "title": "Depressed in the ED vs Cognitively Impaired in the ED: Depression and Cognitive Impairment at 2 Weeks",
        "summary": "27 of 803 against 5 of 808; risk difference 2.7 points, 95% interval 1.4 to 4.3; NCT00717041, Epidemiology of Depression, Anxiety, and Cognitive Impairment",
        "record": "/library/comparisons/NCT00717041-e320f201",
        "nct_id": "NCT00717041",
        "kind": "outcome",
        "participants": 1611,
        "risk_difference": {
          "value": 0.02743579152435792,
          "lower": 0.014171279442235741,
          "upper": 0.042707383170181856
        },
        "group_1": "27 of 803",
        "group_2": "5 of 808",
        "difference": "2.7 points",
        "interval": "1.4 to 4.3",
        "trial_title": "Epidemiology of Depression, Anxiety, and Cognitive Impairment"
      },
      {
        "id": "NCT03168776-4c8b86e5",
        "title": "BuMA Supreme Coronary Stent System (ITT) vs Durable Polymer EES (XIENCE or Promus DES) (ITT): Procedure Success",
        "summary": "1042 of 1074 against 514 of 537; risk difference 1.3 points, 95% interval -0.5 to 3.5; NCT03168776, PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease",
        "record": "/library/comparisons/NCT03168776-4c8b86e5",
        "nct_id": "NCT03168776",
        "kind": "outcome",
        "participants": 1611,
        "risk_difference": {
          "value": 0.013035381750465591,
          "lower": -0.005473762832930797,
          "upper": 0.03537915955357974
        },
        "group_1": "1,042 of 1,074",
        "group_2": "514 of 537",
        "difference": "1.3 points",
        "interval": "-0.5 to 3.5",
        "trial_title": "PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=205",
  "request_id": "VI-jAC5C7efCv8Ow"
}